Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J Helman

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
The Journal of Biological Chemistry|November 24, 1995
Concordant loss of imprinting of the human insulin-like growth factor II gene promoters in cancerS Zhan, D Shapiro, S Zhan, et al.
The Journal of Clinical Investigation|August 1, 1993
Secretory protein traffic. Chromogranin A contains a dominant targeting signal for the regulated pathwayR J Parmer, X P Xi, H J Wu, et al.
Cancer Research|September 15, 2000
XAGE-1, a new gene that is frequently expressed in Ewing's sarcomaX F Liu, L J Helman, C Yeung, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|March 1, 1995
Insulin-like growth factor II overexpression in myoblasts induces phenotypic changes typical of the malignant phenotypeC P Minniti, D Luan, C O'Grady, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1990
Molecular cloning of beta 3 subunit, a third form of the G protein beta-subunit polypeptideM A Levine, P M Smallwood, P T Moen, et al.
DNA and Cell Biology|March 21, 1998
p53 regulates human insulin-like growth factor II gene expression through active P4 promoter in rhabdomyosarcoma cellsL Zhang, Q Zhan, S Zhan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Retinoic acid and cAMP differentially regulate human chromogranin A promoter activity during differentiation of neuroblastoma cellsC Gaetano, I Manni, G Bossi, et al.
The Journal of Clinical Investigation|February 1, 1991
Insulin-like growth factor II-mediated proliferation of human neuroblastomaO M El-Badry, L J Helman, J Chatten, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 1, 1990
Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumorsO M El-Badry, C Minniti, E C Kohn, et al.
Endocrinology|February 1, 1996
Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptorV A Blakesley, T Kalebic, L J Helman, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
The Journal of Biological Chemistry|November 24, 1995
Concordant loss of imprinting of the human insulin-like growth factor II gene promoters in cancerS Zhan, D Shapiro, S Zhan, et al.
The Journal of Clinical Investigation|August 1, 1993
Secretory protein traffic. Chromogranin A contains a dominant targeting signal for the regulated pathwayR J Parmer, X P Xi, H J Wu, et al.
Cancer Research|September 15, 2000
XAGE-1, a new gene that is frequently expressed in Ewing's sarcomaX F Liu, L J Helman, C Yeung, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|March 1, 1995
Insulin-like growth factor II overexpression in myoblasts induces phenotypic changes typical of the malignant phenotypeC P Minniti, D Luan, C O'Grady, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1990
Molecular cloning of beta 3 subunit, a third form of the G protein beta-subunit polypeptideM A Levine, P M Smallwood, P T Moen, et al.
DNA and Cell Biology|March 21, 1998
p53 regulates human insulin-like growth factor II gene expression through active P4 promoter in rhabdomyosarcoma cellsL Zhang, Q Zhan, S Zhan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Retinoic acid and cAMP differentially regulate human chromogranin A promoter activity during differentiation of neuroblastoma cellsC Gaetano, I Manni, G Bossi, et al.
The Journal of Clinical Investigation|February 1, 1991
Insulin-like growth factor II-mediated proliferation of human neuroblastomaO M El-Badry, L J Helman, J Chatten, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 1, 1990
Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumorsO M El-Badry, C Minniti, E C Kohn, et al.
Endocrinology|February 1, 1996
Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptorV A Blakesley, T Kalebic, L J Helman, et al.
Pageof 8